{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:17:51Z","timestamp":1790716671628,"version":"4.1.0"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.pnpbp.2026.111876","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T23:03:32Z","timestamp":1785884612000},"page":"111876","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Prognostic factors and tumor predictors in anti-AMPAR encephalitis: A combined cohort analysis"],"prefix":"10.1016","volume":"149","author":[{"given":"Qingyong","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengru","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongxiao","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.pnpbp.2026.111876_bb0005","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S1474-4422(08)70224-2","article-title":"Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies","volume":"7","author":"Dalmau","year":"2008","journal-title":"Lancet Neurol."},{"issue":"2","key":"10.1016\/j.pnpbp.2026.111876_bb0010","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1152\/physrev.00010.2016","article-title":"Autoantibodies to synaptic receptors and neuronal cell surface proteins in autoimmune diseases of the central nervous system","volume":"97","author":"Dalmau","year":"2017","journal-title":"Physiol. Rev."},{"issue":"24","key":"10.1016\/j.pnpbp.2026.111876_bb0015","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1212\/WNL.0000000000001682","article-title":"Encephalitis and AMPA receptor antibodies: novel findings in a case series of 22 patients","volume":"84","author":"H\u00f6ftberger","year":"2015","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111876_bb0020","doi-asserted-by":"crossref","DOI":"10.1186\/s12905-023-02636-1","article-title":"Anti-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor encephalitis developed after ovarian cancer cytoreduction surgery: a case report and literature review","volume":"23","author":"Huang","year":"2023","journal-title":"BMC Womens Health"},{"issue":"3","key":"10.1016\/j.pnpbp.2026.111876_bb0025","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.1528","article-title":"Limbic encephalitis associated with AMPA receptor and CRMP5 antibodies: a case report and literature review","volume":"10","author":"Jia","year":"2020","journal-title":"Brain Behav."},{"issue":"10","key":"10.1016\/j.pnpbp.2026.111876_bb0030","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1001\/jamaneurol.2015.1715","article-title":"Clinical spectrum of encephalitis associated with antibodies against the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor: case series and review of the literature","volume":"72","author":"Joubert","year":"2015","journal-title":"JAMA Neurol."},{"issue":"4","key":"10.1016\/j.pnpbp.2026.111876_bb0035","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/ana.21589","article-title":"AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location","volume":"65","author":"Lai","year":"2009","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.pnpbp.2026.111876_bb0040","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1007\/s00415-018-9153-8","article-title":"Patient characteristics and outcome associations in AMPA receptor encephalitis","volume":"266","author":"Laurido-Soto","year":"2019","journal-title":"J. Neurol."},{"issue":"9","key":"10.1016\/j.pnpbp.2026.111876_bb0045","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.1007\/s10072-023-06769-x","article-title":"Patient characteristics and outcome in patients with anti-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) encephalitis","volume":"44","author":"Lin","year":"2023","journal-title":"Neurol. Sci."},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111876_bb0050","doi-asserted-by":"crossref","DOI":"10.1186\/s12883-019-1358-7","article-title":"Anti-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor GluR2 encephalitis in a myasthenia gravis patient with complete thymectomy: a case report","volume":"19","author":"Luo","year":"2019","journal-title":"BMC Neurol."},{"key":"10.1016\/j.pnpbp.2026.111876_bb0055","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1237140","article-title":"Case report: seropositive myasthenia gravis complicated by limbic encephalitis positive for antibodies to AMPAR and Lgi1","volume":"14","author":"Nes","year":"2023","journal-title":"Front. Neurol."},{"issue":"12","key":"10.1016\/j.pnpbp.2026.111876_bb0060","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1586\/14737175.2015.1115720","article-title":"Immune therapy in autoimmune encephalitis: a systematic review","volume":"15","author":"Nosadini","year":"2015","journal-title":"Expert. Rev. Neurother."},{"issue":"7","key":"10.1016\/j.pnpbp.2026.111876_bb0065","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.2169\/internalmedicine.9682-17","article-title":"Clinical relapse of anti-AMPAR encephalitis associated with recurrence of thymoma","volume":"57","author":"Omi","year":"2018","journal-title":"Intern. Med."},{"issue":"4","key":"10.1016\/j.pnpbp.2026.111876_bb0070","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/hmg\/11.4.397","article-title":"Aire deficient mice develop multiple features of APECED phenotype and show altered immune response","volume":"11","author":"Ramsey","year":"2002","journal-title":"Hum. Mol. Genet."},{"issue":"4","key":"10.1016\/j.pnpbp.2026.111876_bb0075","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001019","article-title":"Autoimmune global amnesia as manifestation of AMPAR encephalitis and neuropathologic findings","volume":"8","author":"Ricken","year":"2021","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"2","key":"10.1016\/j.pnpbp.2026.111876_bb0080","doi-asserted-by":"crossref","DOI":"10.1111\/cns.14568","article-title":"Thymoma-associated autoimmune encephalitis with myasthenia gravis: case series and literature review","volume":"30","author":"Su","year":"2024","journal-title":"CNS Neurosci. Ther."},{"issue":"2","key":"10.1016\/j.pnpbp.2026.111876_bb0085","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","article-title":"Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study","volume":"12","author":"Titulaer","year":"2013","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111876_bb0090","doi-asserted-by":"crossref","DOI":"10.1186\/s12883-021-02520-1","article-title":"Clinical characteristics and prognosis of anti-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor encephalitis","volume":"21","author":"Zhang","year":"2021","journal-title":"BMC Neurol."}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584626002745?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584626002745?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:44:35Z","timestamp":1790714675000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584626002745"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":18,"alternative-id":["S0278584626002745"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2026.111876","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic factors and tumor predictors in anti-AMPAR encephalitis: A combined cohort analysis","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2026.111876","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111876"}}